Ebitda Cambio Fecha
AbbVie USD 6.75B 433M 2023-09
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
ALKERMES USD 68.51M 189.7M 2023-09
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amgen USD 3.66B 713M 2023-12
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bluebird Bio USD -83657000 670K 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
GlaxoSmithKline GBP 3.17B 729M 2023-09
Incyte USD 226.99M 9.73M 2023-12
J&J USD 6.46B 1.51B 2023-12
Merck USD 7.51B 11.02B 2023-09
Moderna USD 209M 1.97B 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Sarepta Therapeutics USD -9914000 112.81M 2023-09
United Therapeutics USD 277.4M 62.9M 2023-12
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Gilead Sciences - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.